Class IIIOngoingD-0838-2026
Drug recall · September 9, 2026
Revcovi recall
Why: Failed Stability Specifications: Out of specification stability result for the protein concentration profile.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. by Chiesi USA, Inc., Cary, NC 27518, NDC 10122-502-01
- Lots / codes
Lot#: 1221973, Exp 3/24/2027
- Quantity
- 3,002 vials
- Company
- Chiesi USA, Inc., Cary, NC
- Distribution
- MO, TN
- Initiated
- August 19, 2026 · Voluntary: Firm initiated
- Classified
- September 11, 2026
- Reported
- September 9, 2026
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.